Yuriy's goal is to accelerate medical research and improve patient care to significantly extend human lifespan and healthspan. Prior to founding Aiternis Yuriy co-founded Alvansa pharmaceutical holding with a total investment of $200M. Raised $58M in PIPE for Affitech, NASDAQ OMX Copenhagen listed cancer research company. Yuriy is the shareholder of CureLab Oncology Inc. a US based oncology gene therapy drug development company. He worked as Director of Licensing and Business Development at the HSCI - company that registered and brought to the market one of the first 5 gene therapy drugs. Graduated from the Moore School, University of South Carolina.
Yuriy Oreshin, Founder and CEO of Aiternis
Our website is almost ready.
Please submit your information below to contact Aiternis: